Associate Professor, Department of Bioinformatics and Computational Biology
Dmitri Klimov uses computer simulations to study Alzheimer’s disease. His research focuses on the formation of starchlike protein assemblies that accumulate in body tissues called amyloid fibrils and their role in the development of Alzheimer’s disease. He is also interested in the use of non-steroidal anti-inflammatory drugs, such as ibuprofen, in the treatment of Alzheimer’s disease. He has published more than 57 papers and recently received a half-million dollar grant from the National Institutes of Health in support of his research. Prior to joining Mason, Klimov worked as an assistant research scientist at the Institute for Physical Science and Technology at the University of Maryland at College Park.
Media Contact: Michele McDonald, 703-993-8781, email@example.com